コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sed accumulation of immune suppressor cells (myeloid-derived suppressor cells).
2 We suggest that these cells may be myeloid derived suppressor cells.
3 educe infiltration of T regulatory cells and myeloid-derived suppressor cells.
4 ritical for immune suppressive activities of myeloid-derived suppressor cells.
5 , B cells, NK cells, regulatory T cells, and myeloid-derived suppressor cells.
6 g endothelial, haematopoietic progenitor and myeloid-derived suppressor cells.
7 ruitment of tumor-associated macrophages and myeloid-derived suppressor cells.
8 ms, that is, they exhibit characteristics of myeloid-derived suppressor cells.
9 nts with lung cancer: regulatory T cells and myeloid-derived suppressor cells.
10 accumulation of regulatory T cells cells and myeloid-derived suppressor cells.
11 ing Tol-DC, Rapa-DC, DC-10, and PGE2-induced myeloid-derived suppressor cells.
12 a receptor 1 expressed on tumor infiltrating myeloid-derived suppressor cells.
13 limited to F4/80(+) macrophages and Ly-6C(+) myeloid-derived suppressor cells.
14 onment that harbored more M2 macrophages and myeloid-derived suppressor cells.
15 and metastasis associated with expansion of myeloid-derived suppressor cells.
16 g macrophages and granulocytic and monocytic myeloid-derived suppressor cells.
21 TME by decreasing the presence of monocytic myeloid-derived suppressor cells and increasing the pres
22 environment characterized by an abundance of myeloid-derived suppressor cells and inhibition of cytot
23 esulted in the recruitment of both monocytic myeloid-derived suppressor cells and macrophages, thereb
25 y anti-EphA2 CD8+ T cells, reduced levels of myeloid-derived suppressor cells and regulatory T cells
26 ty is attenuated by cell populations such as myeloid-derived suppressor cells and regulatory T cells,
27 r microenvironment, including development of myeloid-derived suppressor cells and regulatory T cells;
28 ystemic immunoregulatory mediators TGF-beta, myeloid-derived suppressor cells and regulatory T-cells.
29 mour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour grow
31 immunosuppression in cancer (in the form of myeloid-derived suppressor cells) and, more recently, in
32 esenting Ag, notwithstanding the presence of myeloid-derived suppressor cells, and CD8(+) dendritic c
33 dendritic cells (pDCs), regulatory T cells, myeloid-derived suppressor cells, and CD8(+) regulatory
34 in PD-1(+)Lag3(+) T cells and CD11(+)Gr1(+) myeloid-derived suppressor cells, and changes in the che
37 by regulatory T cells, type II macrophages, myeloid-derived suppressor cells, and other immunosuppre
38 mber of M2-type macrophages and granulocytic myeloid-derived suppressor cells, and protumor T-regulat
39 ted with increases in regulatory T cells and myeloid-derived suppressor cells, and the leukemic cells
40 roblasts, the hematopoietic stem cell niche, myeloid-derived suppressor cells, and the sympathetic ne
41 r T-cell function, and expansion of immature myeloid-derived suppressor cells are all contributory.
42 d tumor polymorphonuclear cells/granulocytic myeloid-derived suppressor cells are due to the loss of
44 , including tumor-associated macrophages and myeloid-derived suppressor cells, are abundant in the HC
45 d with a large expansion of Gr-1(+) CD11b(+) myeloid-derived suppressor cells, as well as elevated le
46 hibited accumulation of CD11b+Gr1intF4/80int myeloid-derived suppressor cells at the resection margin
47 ncreatic cancer, predominantly in neutrophil/myeloid-derived suppressor cells, but rarely in tumor ce
48 he complex protein cargo of exosomes shed by myeloid-derived suppressor cells collected under high an
49 tant mice exhibited increased recruitment of myeloid-derived suppressor cells, consistent with protec
50 tumor site, including regulatory T cells and myeloid-derived suppressor cells, correlating with an in
51 with AP had greater numbers of macrophages, myeloid-derived suppressor cells, dendritic cells, and g
52 ibitory effect of phenformin on granulocytic myeloid-derived suppressor cell-driven immune suppressio
53 may be due to depletion of T-regulatory and myeloid-derived suppressor cells during TB infection.
54 These results document the generation of myeloid-derived suppressor cells during TB, suggesting t
55 from dendritic cell (DC) differentiation to myeloid-derived suppressor cell expansion during tumour
56 mmatory cytokines, Ly-6C(hi)G(neg) monocytic myeloid-derived suppressor cells expressing inducible NO
57 acrophages, tolerogenic dendritic cells, and myeloid-derived suppressor cells, for the induction of t
58 lar, phenotypically and functionally, to the myeloid-derived suppressor cells found in cancer because
59 Cs), which are phenotypically similar to the myeloid-derived suppressor cells found in patients with
61 dendritic cells, suppressor macrophages, and myeloid-derived suppressor cells, generated in vitro fro
62 ulatory cells (Treg), Th17, and granulocytic myeloid-derived suppressor cells (gMDSC) were increased
63 decreased the frequency of immunosuppressive myeloid-derived suppressor cells in a syngeneic TNBC mou
64 D33+S100A9+ cells, the phenotype typical for myeloid-derived suppressor cells in cancer or immature m
65 s in vivo and found they differentiated into myeloid-derived suppressor cells in early metastatic sit
66 phenformin selectively inhibits granulocytic myeloid-derived suppressor cells in spleens of tumor-bea
67 st cancer cells revealed the accumulation of myeloid-derived suppressor cells in the lung and liver.
68 elial cells not only reduced tumor-promoting myeloid-derived suppressor cells in the lung, but also d
69 C5a receptor deficiency, which also lessens myeloid-derived suppressor cells in the premetastatic ni
70 nd reduces the percentage of macrophages and myeloid-derived suppressor cells in the tumor microenvir
71 he expansion of neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvir
72 uppressive cytokines, including TGF-beta, by myeloid-derived suppressor cells in tumor-draining lymph
73 (mMDSC) and granulocytic (gMDSC) subsets of myeloid-derived suppressor cells infiltrate in the prima
74 tion and tumor cell killing while decreasing myeloid-derived suppressor cell infiltration and IL10 pr
75 also stabilizes the suppressive function of myeloid-derived suppressor cells, inhibits the release o
76 esis that TGF-beta drives differentiation of myeloid-derived suppressor cells into protumorigenic ter
77 he TGF-beta signaling mediates maturation of myeloid-derived suppressor cells into TDMMCs with high l
78 rived TLR2/6 heterodimer ligands can recruit myeloid-derived suppressor cells into the skin, counteri
79 ut of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause
80 characterized by a balanced distribution of myeloid-derived suppressor cell-like and APC-like myeloi
83 l subsets include monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) define
85 iltration of neutrophils, T cells, monocytic myeloid-derived suppressor cells (M-MDSCs), and group 2
86 munosuppressive myeloid cells expressing the myeloid-derived suppressor cell marker S100A9 only in a
87 rived conditioned medium differentiated into myeloid derived suppressor cells (MDSC) (CD33(+)CD11b(+)
88 e activation, have an increased frequency of myeloid derived suppressor cells (MDSC) and are at incre
90 factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation a
92 d with tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) infiltration in t
93 igrated to the stomach, where they exhibited myeloid-derived suppressor cell (MDSC) markers and acqui
94 34(+) (fibrocytes) and (ii) CD45(+) CD34(-) [myeloid-derived suppressor cell (MDSC)-like fibrocytes]
95 derived dendritic cells were driven toward a myeloid-derived suppressor cell (MDSC)-like phenotype by
96 edgehog-driven tumors exhibit an increase in myeloid-derived suppressor cells (MDSC) and a decrease i
97 ruitment and accumulation of lung-associated myeloid-derived suppressor cells (MDSC) and MDSC-derived
109 We have shown that cotransplantation with myeloid-derived suppressor cells (MDSC) effectively prot
112 hepatic stellate cells allowed generation of myeloid-derived suppressor cells (MDSC) from precursors
113 r, its role in the expansion and function of myeloid-derived suppressor cells (MDSC) has not been det
115 )) and monocytic (CD11b(+)Ly6G(-)Ly6C(high)) myeloid-derived suppressor cells (MDSC) in chronically i
116 e numbers and function of tumor-infiltrating myeloid-derived suppressor cells (MDSC) in ganglioside-d
118 in marked contrast, it reduced the levels of myeloid-derived suppressor cells (MDSC) in mice bearing
119 triggers robust induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) in the peritoneu
120 f melanoma is associated with restoration of myeloid-derived suppressor cells (MDSC) in the tumor mic
121 In this study, we show the importance of myeloid-derived suppressor cells (MDSC) in this process
122 arrier to efficacy may be the recruitment of myeloid-derived suppressor cells (MDSC) into the tumor m
125 static liver tissue recruited CXCR2-positive myeloid-derived suppressor cells (MDSC) to form a premet
126 (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurre
127 he G-CSF-driven mobilization of granulocytic myeloid-derived suppressor cells (MDSC) to the breast ca
128 8(+) T cells, regulatory T cells (Treg), and myeloid-derived suppressor cells (MDSC) were profiled by
129 ) delivery of paclitaxel to tumor-associated myeloid-derived suppressor cells (MDSC), (ii) MPO-regula
130 ing in hematopoietic progenitor cells (HPC), myeloid-derived suppressor cells (MDSC), and dendritic c
131 We evaluated T regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and exhausted T
132 resistance to immune suppression mediated by myeloid-derived suppressor cells (MDSC), as derived from
133 ing with marked increases in CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC), FoxP3(+) regula
135 macrophages (TAM), and CD11b(+)Gr-1 (LY6G)+ myeloid-derived suppressor cells (MDSC), respond to canc
136 tumors is associated with an accumulation of myeloid-derived suppressor cells (MDSC), the numbers of
140 ruiting regulatory T cells (Treg) and innate myeloid-derived suppressor cells (MDSC), which facilitat
141 otes immunosuppression by tumor-infiltrating myeloid-derived suppressor cells (MDSC), which inhibit h
157 has been reported to induce the expansion of myeloid-derived suppressor cells (MDSC); however, little
160 KDR expression increased in myeloid cells as myeloid-derived suppressor cells (MDSCs) accumulated, wh
164 ells exhibited all of the characteristics of myeloid-derived suppressor cells (MDSCs) and exerted sup
165 expansion of inflammatory cells that include myeloid-derived suppressor cells (MDSCs) and IL-13(+) Th
166 TAT1 in TM40D cells promoted mobilization of myeloid-derived suppressor cells (MDSCs) and inhibition
167 secretome to drive monocyte polarization to myeloid-derived suppressor cells (MDSCs) and M2-like mac
168 nduced the recruitment of CD49d(+) monocytic myeloid-derived suppressor cells (MDSCs) and regulatory
169 studied the regulatory mechanism mediated by myeloid-derived suppressor cells (MDSCs) and showed that
170 opulation that was phenotypically similar to myeloid-derived suppressor cells (MDSCs) and that suppre
171 ed the infiltration of myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-assoc
172 Tumor-infiltrating myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-assoc
178 y contributes to cancer metastasis, in which myeloid-derived suppressor cells (MDSCs) are an importan
190 s during EAE induction, with CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) as the most exp
191 mote the differentiation and accumulation of myeloid-derived suppressor cells (MDSCs) both in vitro a
201 stellate cells induce the differentiation of myeloid-derived suppressor cells (MDSCs) from myeloid pr
208 pase (LAL) deficiency causes infiltration of myeloid-derived suppressor cells (MDSCs) in multiple org
209 ycolipid-activated iNKT cells cooperate with myeloid-derived suppressor cells (MDSCs) in protecting m
210 We recently identified a critical role for myeloid-derived suppressor cells (MDSCs) in S. aureus bi
212 of Blood, Hou et al show the involvement of myeloid-derived suppressor cells (MDSCs) in the pathogen
213 vered the induction of the immunosuppressive myeloid-derived suppressor cells (MDSCs) in the spleen b
215 functional studies to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor mi
217 Jitschin et al identify increased numbers of myeloid-derived suppressor cells (MDSCs) in untreated pa
220 dition to their immune-suppressive activity, myeloid-derived suppressor cells (MDSCs) influence tumor
223 rigenesis through inhibiting infiltration of myeloid-derived suppressor cells (MDSCs) into colonic mu
224 cell responses in tumor microenvironments by myeloid-derived suppressor cells (MDSCs) is widely accep
225 ry Th1 and Th17 cells, accumulation of donor myeloid-derived suppressor cells (MDSCs) mediated by ILC
226 el, we show an expansion of Gr-1(+) CD11b(+) myeloid-derived suppressor cells (MDSCs) occurring intra
232 ical NO concentrations produced by patients' myeloid-derived suppressor cells (MDSCs) support the dev
233 le 11b (CD11b), lymphocyte antigen 6G (Ly6G) myeloid-derived suppressor cells (MDSCs) that caused mye
234 of a population of cells with similarity to myeloid-derived suppressor cells (MDSCs) that may have s
235 ased proportion of immunosuppressive CD33(+) myeloid-derived suppressor cells (MDSCs) that negatively
237 ited CD11b(+)Gr-1(high)Ly-6C(+) granulocytic myeloid-derived suppressor cells (MDSCs) to the liver of
238 1(low)CD11c(+) MDCs and Gr-1(high)CD11c(neg) myeloid-derived suppressor cells (MDSCs) were enriched i
241 WT, but not IFNAR-deficient mice, monocytic myeloid-derived suppressor cells (MDSCs) were recruited
242 a highly immune suppressive subpopulation of myeloid-derived suppressor cells (MDSCs) within the tumo
243 allograft survival by cotransplantation with myeloid-derived suppressor cells (MDSCs) without require
244 b(+) populations were increased, notably the myeloid-derived suppressor cells (MDSCs), a CD11b(+) sub
245 noncytotoxic dose paclitaxel on functions of myeloid-derived suppressor cells (MDSCs), chronic inflam
246 11b+Gr1+Ly6C+Ly6G-F4/80(low)) with monocytic myeloid-derived suppressor cells (MDSCs), had similar mo
247 Recently, a novel subset of innate cells, myeloid-derived suppressor cells (MDSCs), has been descr
248 ally and functionally resemble tumor-induced myeloid-derived suppressor cells (MDSCs), indicating an
252 ry hematopoiesis and massive accumulation of myeloid-derived suppressor cells (MDSCs), which actively
253 ns induces a distinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs), which function
254 the local accumulation of tumor-infiltrating myeloid-derived suppressor cells (MDSCs), which suppress
270 cells that infiltrated from the circulation (myeloid-derived suppressor cells [MDSCs], monocyte-deriv
271 +; 95% CI, 1.13-8.35; P = .01) and monocytic myeloid derived suppressor cells (mMDSC) (95% CI, 3.62-1
273 gates cytokine-driven expansion of monocytic myeloid-derived suppressor cells (mMDSC) from human or m
274 et al. report increased numbers of monocytic myeloid-derived suppressor cells (Mo-MDSC) in psoriasis
275 Recently, CD14(+) HLA-DR(-/low) monocytic myeloid-derived suppressor cells (Mo-MDSCs) have been sh
277 ells, dendritic cells, natural killer cells, myeloid-derived suppressor cells, neutrophils, or macrop
279 In contrast to tumor-associated macrophages, myeloid-derived suppressor cells, or inflammatory monocy
280 Furthermore, secreted tissue signals and myeloid-derived suppressor cell populations were altered
283 ine profiles and high levels of granulocytic myeloid-derived suppressor cells resulted in loss of imm
284 herwise potent anti-inflammatory function of myeloid-derived suppressor cells, revealing a novel mech
285 ture granulocytes, we identified a CD14/CD24 myeloid-derived suppressor cell subset with the capabili
286 ssion of numerous immune factors involved in myeloid-derived suppressor cell survival and trafficking
287 macrophages, regulatory dendritic cells, and myeloid-derived suppressor cells to regulate alloimmunit
288 y mediating the recruitment of monocytes and myeloid-derived suppressor cells to the tumor microenvir
289 ctivation of immunosuppressive cells such as myeloid-derived suppressor cells, tolerogenic monocytes,
292 parable elevations of T-regulatory cells and myeloid-derived suppressor cells were observed in both r
293 n of reactive oxygen species in granulocytic myeloid-derived suppressor cells, whereas the antioxidan
294 ly sepsis deterioration and were enriched in myeloid-derived suppressor cells which could be responsi
296 us describe a novel subset of cancer-induced myeloid-derived suppressor cells, which bear the phenoty
297 ent include tumor-associated macrophages and myeloid-derived suppressor cells, which not only mediate
298 nd P38 MAPK signaling responses in monocytic myeloid-derived suppressor cells, which was paired with
299 otal content of effector T cells, Tregs, and myeloid-derived suppressor cells, while effector T cells
300 Further study revealed a subpopulation of myeloid-derived suppressor cells within the CD11b(+) Gr-
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。